Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

17 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Low-dose ritonavir-boosted darunavir once daily versus ritonavir-boosted lopinavir for participants with less than 50 HIV RNA copies per mL (WRHI 052): a randomised, open-label, phase 3, non-inferiority trial.
Venter WDF, Moorhouse M, Sokhela S, Serenata C, Akpomiemie G, Qavi A, Mashabane N, Arulappan N, Sim JW, Sinxadi PZ, Wiesner L, Maharaj E, Wallis C, Boyles T, Ripin D, Stacey S, Chitauri G, Hill A. Venter WDF, et al. Among authors: mashabane n. Lancet HIV. 2019 Jul;6(7):e428-e437. doi: 10.1016/S2352-3018(19)30081-5. Epub 2019 Jun 12. Lancet HIV. 2019. PMID: 31202690 Clinical Trial.
Implementation of an mHealth App to Promote Engagement During HIV Care and Viral Load Suppression in Johannesburg, South Africa (iThemba Life): Pilot Technical Feasibility and Acceptability Study.
Lalla-Edward ST, Mashabane N, Stewart-Isherwood L, Scott L, Fyvie K, Duncan D, Haile B, Chugh K, Zhou Y, Reimers J, Pan M, Venkatraman M, Stevens W. Lalla-Edward ST, et al. Among authors: mashabane n. JMIR Form Res. 2022 Feb 2;6(2):e26033. doi: 10.2196/26033. JMIR Form Res. 2022. PMID: 35107427 Free PMC article.
Final 192-Week Efficacy and Safety Results of the ADVANCE Trial, Comparing 3 First-line Antiretroviral Regimens.
Sokhela S, Venter WDF, Bosch B, Woods J, McCann K, Akpomiemie G, Chandiwana N, Mashabane N, Tembo A, Simmons B, Lalla-Edward S, Siedner MJ, Sinxadi P, Hermans L, Fairlie L, Vos A, Abrams E, Manne-Goehler JM, Moorhouse M, Clayden P, Norris S, Qavi A, Chersich M, Masenya M, Arulappan N, Hill A. Sokhela S, et al. Among authors: mashabane n. Open Forum Infect Dis. 2024 Jan 24;11(3):ofae007. doi: 10.1093/ofid/ofae007. eCollection 2024 Mar. Open Forum Infect Dis. 2024. PMID: 38529213 Free PMC article.
The cost of adding rapid screening for diabetes, hypertension, and COVID-19 to COVID-19 vaccination queues in Johannesburg, South Africa.
Masuku SD, Brennan AT, Vetter B, Venter F, Mtshazo B, Sokhela S, Mashabane N, Kao K, Meyer-Rath G. Masuku SD, et al. Among authors: mashabane n. Res Sq [Preprint]. 2023 Oct 10:rs.3.rs-3393141. doi: 10.21203/rs.3.rs-3393141/v1. Res Sq. 2023. Update in: BMC Public Health. 2024 Jul 16;24(1):1900. doi: 10.1186/s12889-024-19253-8 PMID: 37886557 Free PMC article. Updated. Preprint.
Response to comments by Taramasso and colleagues on weight gain stopping/switch rules for antiretroviral clinical trials.
Venter F, Sokhela S, Calmy A, Siedner MJ, Khoo S, Clayden P, Mkhondwane L, Bosch B, Chandiwana N, Hill A, Marconi VC, Boffito M, Sekwese K, Ali M, Delaporte E, Pozniak A, Mashabane N, Lalla-Edwards S, Carman M, Collins S. Venter F, et al. Among authors: mashabane n. AIDS. 2022 Nov 1;36(13):1900-1901. doi: 10.1097/QAD.0000000000003310. AIDS. 2022. PMID: 36172876 No abstract available.
17 results